In the present study, we elucidated the previously unexplored role of the gut microbiome in the regulation of HCC patient response to RT and described a crucial link between bacterial c-di-AMP and the host cGAS–STING pathway via the gut microbiome–liver axis (Figure 6). This evidence concerns the gene STING1 and hepatocellular carcinoma.